Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Haworthia plant named `AMSTERDAM`
Satellite mounting pole
Method and composition for attracting arthropods by volatizing an acid
Die seal ring
Image scanner and image forming apparatus
Method of operating a split gate flash memory cell with coupling gate
Orthogonal tunable antenna array for wireless communication devices
  Randomly Featured Patents
Process of making regenerated cellulose articles
Nonaqueous battery with organic compound cathode
Device for controlling the opening and shutting movement of sliding elevator doors
Packet router having improved packet classification
Fluorescent proteins and related methods and compounds
Twin beam spotlight
Absorbent article with hydrophilic aggregates in topsheet
Method of investment casting with casting identification
Self-locking automatically-releasing sash balance for tiltably-removable sliding sash windows
Method of delivering a protein to poultry